Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease

Area of Science:

• Nephrology
• Vascular Biology
• Regenerative Medicine

Background:

• Endothelial progenitor cells (EPCs) are crucial for vascular repair.
• Chronic kidney disease (CKD) may compromise EPC number and function.
• Understanding EPC status in CKD is vital for managing cardiovascular risks.

Purpose of the Study:

• To assess the number and angiogenic function of EPCs in patients with varying stages of CKD.
• To investigate the relationship between EPC characteristics and CKD progression.
• To evaluate the potential of EPCs for regenerative medicine in CKD.

Main Methods:

• Cross-sectional, prospective study including 50 CKD patients and 10 healthy controls.
• Isolation of mononuclear cells and quantification of circulating EPCs (CD14+, CD34+) via flow cytometry.
• Assessment of EPC angiogenic capacity using fibronectin-coated films and culture under angiogenic conditions.

Main Results:

• CKD patients showed normal CD14+ EPC counts but reduced CD34+ EPC numbers.
• EPCs from CKD patients exhibited functional deficits: impaired adherence, reduced outgrowth, and diminished antithrombogenic function.
• These impairments were evident from Stage 1 CKD and worsened with disease progression; dialysis offered only partial improvement.

Conclusions:

• EPC number and function significantly decrease with advancing CKD.
• Compromised EPCs may hinder vascular repair mechanisms in CKD patients.
• Reduced EPC capacity contributes to the elevated cardiovascular disease risk associated with CKD.